instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Hepatic encephalopathy'? | Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.
Immune checkpoint inhibitors (ICI) have been used to treat hepatocellular carcinoma (HCC) since 2017. The safety of ICIs in the setting of solid organ transplantation remains controversial. When ... | Recovered | ReactionOutcome | CC BY | 34643885 | 20,041,613 | 2021-12 |
What was the outcome of reaction 'Hepatic necrosis'? | Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.
Immune checkpoint inhibitors (ICI) have been used to treat hepatocellular carcinoma (HCC) since 2017. The safety of ICIs in the setting of solid organ transplantation remains controversial. When ... | Recovered | ReactionOutcome | CC BY | 34643885 | 20,041,613 | 2021-12 |
What was the outcome of reaction 'Transplant rejection'? | Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.
Immune checkpoint inhibitors (ICI) have been used to treat hepatocellular carcinoma (HCC) since 2017. The safety of ICIs in the setting of solid organ transplantation remains controversial. When ... | Recovered | ReactionOutcome | CC BY | 34643885 | 20,041,613 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage intracranial'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes simplex encephalitis'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | ACYCLOVIR, AZATHIOPRINE, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
What was the administration route of drug 'AZATHIOPRINE'? | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | Oral | DrugAdministrationRoute | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
What was the administration route of drug 'PREDNISOLONE'? | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | Oral | DrugAdministrationRoute | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
What was the outcome of reaction 'Circulatory collapse'? | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | Fatal | ReactionOutcome | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
What was the outcome of reaction 'Herpes simplex encephalitis'? | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | Fatal | ReactionOutcome | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
What was the outcome of reaction 'Respiratory failure'? | Next-generation sequencing of cerebrospinal fluid for diagnosis of atypical herpes simplex encephalitis.
OBJECTIVE
Herpes simplex encephalitis (HSE) is one of the most common causes of severe viral encephalitis. The characteristic manifestations of HSE include cerebrospinal fluid with mild cytopenia, dominated by lymph... | Fatal | ReactionOutcome | CC BY-NC | 34644193 | 20,974,168 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | AMLODIPINE BESYLATE, CEFTRIAXONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | AMLODIPINE BESYLATE, CEFTRIAXONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | 2.5 MG | DrugDosageText | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | 1500 MG | DrugDosageText | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
What was the dosage of drug 'PREDNISOLONE'? | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | 5 MG | DrugDosageText | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
What was the dosage of drug 'TACROLIMUS'? | Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review.
BACKGROUND
The use of human intravenous immunoglobulin gamma (IVIG) is associated with thromboembolic events as a complication. There are few reported cases of renal in... | 4 MG | DrugDosageText | CC BY | 34645393 | 20,659,091 | 2021-10-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | An Autopsy Confirmed Neuromyelitis Optica Spectrum Disorder with Extensive Brain White Matter Lesion and Optic Neuritis but Intact Spinal Cord, Clinically Mimicking a Secondary Progressive Multiple Sclerosis-like Course.
A 57-year-old woman presented with optic neuritis with repeated clinical symptoms of focal demyelin... | INTERFERON BETA-1B | DrugsGivenReaction | CC BY-NC-ND | 34645756 | 20,912,654 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchioloalveolar carcinoma'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,943,210 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,171 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,170 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Escherichia sepsis'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,943,203 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal necrosis'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,230 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematemesis'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,943,204 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,943,204 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,171 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia staphylococcal'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,234 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,167 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary oedema'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,943,209 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal sepsis'. | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | DEXAMETHASONE, IXAZOMIB, LENALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34645759 | 20,942,234 | 2021-10-12 |
What was the outcome of reaction 'Bronchioloalveolar carcinoma'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,943,210 | 2021-10-12 |
What was the outcome of reaction 'Condition aggravated'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,171 | 2021-10-12 |
What was the outcome of reaction 'Death'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,170 | 2021-10-12 |
What was the outcome of reaction 'Escherichia sepsis'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,943,203 | 2021-10-12 |
What was the outcome of reaction 'Gastrointestinal necrosis'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,230 | 2021-10-12 |
What was the outcome of reaction 'Haematemesis'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,943,204 | 2021-10-12 |
What was the outcome of reaction 'Pancytopenia'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
What was the outcome of reaction 'Plasma cell myeloma'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,171 | 2021-10-12 |
What was the outcome of reaction 'Pneumonia staphylococcal'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,234 | 2021-10-12 |
What was the outcome of reaction 'Pneumonia'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,167 | 2021-10-12 |
What was the outcome of reaction 'Pulmonary oedema'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,943,209 | 2021-10-12 |
What was the outcome of reaction 'Renal impairment'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
What was the outcome of reaction 'Septic shock'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,168 | 2021-10-12 |
What was the outcome of reaction 'Staphylococcal sepsis'? | Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance.
Objective To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan... | Fatal | ReactionOutcome | CC BY-NC-ND | 34645759 | 20,942,234 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Posterior reversible encephalopathy syndrome'. | A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome Probably Due to Different Etiologies.
A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed repeated posterior reversible encephalopathy ... | AMLODIPINE BESYLATE, NICARDIPINE HYDROCHLORIDE, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34645762 | 20,891,280 | 2021-10-12 |
What was the administration route of drug 'NICARDIPINE HYDROCHLORIDE'? | A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome Probably Due to Different Etiologies.
A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed repeated posterior reversible encephalopathy ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34645762 | 20,891,280 | 2021-10-12 |
What was the administration route of drug 'PREDNISOLONE'? | A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome Probably Due to Different Etiologies.
A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed repeated posterior reversible encephalopathy ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34645762 | 20,891,280 | 2021-10-12 |
What was the outcome of reaction 'Posterior reversible encephalopathy syndrome'? | A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome Probably Due to Different Etiologies.
A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed repeated posterior reversible encephalopathy ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34645762 | 20,891,280 | 2021-10-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atelectasis'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal heart rate deceleration abnormality'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, BETAMETHASONE, CEFTRIAXONE, DALTEPARIN SODIUM, FENTANYL, FUROSEMIDE, HYDROXYCHLOROQUINE, MIDAZOLAM, PROPOFOL | DrugsGivenReaction | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal malpresentation'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, OXYGEN, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,896 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung infiltration'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,891 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Non-cardiogenic pulmonary oedema'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, OXYGEN, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,896 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature labour'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, OXYGEN, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Preterm premature rupture of membranes'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, OXYGEN, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Superimposed pre-eclampsia'. | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | AZITHROMYCIN, CEFTRIAXONE, DALTEPARIN, OXYGEN, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What is the weight of the patient? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | 3 kg. | Weight | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'BETAMETHASONE'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'DALTEPARIN SODIUM'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'DALTEPARIN'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the administration route of drug 'FUROSEMIDE'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'MIDAZOLAM'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'OXYGEN'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Nasal | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What was the administration route of drug 'PROPOFOL'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the administration route of drug 'UNSPECIFIED INGREDIENT'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What was the outcome of reaction 'Atelectasis'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the outcome of reaction 'Foetal heart rate deceleration abnormality'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,614,439 | 2021-09 |
What was the outcome of reaction 'Hypoxia'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the outcome of reaction 'Lung infiltration'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,891 | 2021-09 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the outcome of reaction 'Non-cardiogenic pulmonary oedema'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the outcome of reaction 'Off label use'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What was the outcome of reaction 'Oxygen saturation decreased'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,892 | 2021-09 |
What was the outcome of reaction 'Premature labour'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What was the outcome of reaction 'Preterm premature rupture of membranes'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
What was the outcome of reaction 'Superimposed pre-eclampsia'? | Severe and critical COVID-19 in pregnancy: A case series from Montreal.
Optimal obstetric management for women with coronavirus disease (COVID-19) is not known. We describe the management of six pregnant women requiring in-hospital care for severe COVID-19.
A retrospective chart review was conducted to identify pregnan... | Recovered | ReactionOutcome | CC BY-NC | 34646346 | 20,119,895 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | APREPITANT, DACARBAZINE, DEXAMETHASONE, ONDANSETRON, PALONOSETRON HYDROCHLORIDE, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34646430 | 19,990,029 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | APREPITANT, DACARBAZINE, DEXAMETHASONE, ONDANSETRON, PALONOSETRON HYDROCHLORIDE, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the administration route of drug 'DACARBAZINE'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the administration route of drug 'PEGFILGRASTIM'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'APREPITANT'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 150 MILLIGRAM | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'DACARBAZINE'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 850 MILLIGRAM/SQ. METER (3-WEEK CYCLE) | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 20 MILLIGRAM | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'ONDANSETRON'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 32 MILLIGRAM | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'PALONOSETRON HYDROCHLORIDE'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 0.25 MILLIGRAM | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the dosage of drug 'PEGFILGRASTIM'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | 6 MILLIGRAM | DrugDosageText | CC BY-NC | 34646430 | 19,990,029 | 2021 |
What was the outcome of reaction 'Death'? | Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
Historically, administration of dacarbazine to sarcoma patients was limited by frequent treat-ment-related nausea/vomiting and neutropenia. These toxi... | Fatal | ReactionOutcome | CC BY-NC | 34646430 | 19,990,029 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | CARBOPLATIN, DEXAMETHASONE, PACLITAXEL, PEMBROLIZUMAB, PEMETREXED, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed level of consciousness'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | DEXAMETHASONE, LEVOFLOXACIN, PEMBROLIZUMAB, PEMETREXED, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | CARBOPLATIN, DEXAMETHASONE, LEVOFLOXACIN, PACLITAXEL, PEMBROLIZUMAB, PEMETREXED, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,089,063 | 2021-11 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.